Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Changes in hemostasis during epilespy treatment using dipropyl acetate. Extended study]

A H Sutor, C Jesdinsky-Buscher

    Fortschritte Der Medizin
    |March 11, 1976
    PubMed
    Summary

    Dipropyl-Acetate (DPA) can negatively impact blood clotting. Patients taking DPA may experience prolonged bleeding times, low platelet counts, and reduced platelet function, necessitating hemostasis testing.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Screening children with thrombosis for thrombophilic proteins. Cui bono?

    Journal of thrombosis and haemostasis : JTH·2003
    Same author

    [Catheter-related thrombosis and its prevention in infancy].

    Hamostaseologie·2003
    Same author

    Pro- and anticoagulatory factors under sodium valproate-therapy in children.

    Neuropediatrics·2002
    Same author

    Problems with platelet counting in thrombocytopenia. A rapid manual method to measure low platelet counts.

    Seminars in thrombosis and hemostasis·2001
    Same author

    Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany.

    Seminars in thrombosis and hemostasis·2001
    Same author

    Function of von Willebrand factor in children with diarrhea-associated hemolytic-uremic syndrome (D+ HUS).

    Seminars in thrombosis and hemostasis·2001

    Area of Science:

    • Pharmacology
    • Hematology
    • Clinical Medicine

    Background:

    • Dipropyl-Acetate (DPA), also known as Ergenyl, is a medication with potential effects on hemostasis.
    • Understanding the impact of DPA on blood clotting is crucial for patient safety.

    Observation:

    • The study observed 12 patients undergoing treatment with Dipropyl-Acetate.
    • Hemostasis parameters were monitored to assess the drug's influence on blood clotting mechanisms.

    Findings:

    • A significant prolongation of bleeding time was noted in 8 out of 12 patients.
    • Thrombocytopenia (low platelet count) occurred in 2 patients.
    • Platelet adhesiveness was pathologically reduced in 6 out of 10 patients evaluated.

    Implications:

    • The findings suggest DPA adversely affects platelet function and coagulation.
    • Routine hemostasis examinations, particularly focusing on the thrombocytic system, are recommended for patients prescribed DPA.
    • This monitoring can help prevent or manage potential bleeding complications associated with DPA therapy.

    Related Experiment Videos